These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 20800375)

  • 1. Clinical outcome of hypofractionated stereotactic radiotherapy for abdominal lymph node metastases.
    Bignardi M; Navarria P; Mancosu P; Cozzi L; Fogliata A; Tozzi A; Castiglioni S; Carnaghi C; Tronconi MC; Santoro A; Scorsetti M
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):831-8. PubMed ID: 20800375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical appraisal of volumetric modulated arc therapy in stereotactic body radiation therapy for metastases to abdominal lymph nodes.
    Bignardi M; Cozzi L; Fogliata A; Lattuada P; Mancosu P; Navarria P; Urso G; Vigorito S; Scorsetti M
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1570-7. PubMed ID: 19880261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases.
    Yeung R; Hamm J; Liu M; Schellenberg D
    Radiat Oncol; 2017 Jun; 12(1):105. PubMed ID: 28637480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linac-based stereotactic body radiotherapy for oligometastatic patients with single abdominal lymph node recurrent cancer.
    Jereczek-Fossa BA; Piperno G; Ronchi S; Catalano G; Fodor C; Cambria R; Fossati Ing P; Gherardi F; Alterio D; Zerini D; Garibaldi C; Baroni G; De Cobelli O; Orecchia R
    Am J Clin Oncol; 2014 Jun; 37(3):227-33. PubMed ID: 22992626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic Body Radiotherapy for Recurrent or Oligometastatic Uterine Cervix Cancer: A Cooperative Study of the Korean Radiation Oncology Group (KROG 14-11).
    Park HJ; Chang AR; Seo Y; Cho CK; Jang WI; Kim MS; Choi C
    Anticancer Res; 2015 Sep; 35(9):5103-10. PubMed ID: 26254414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Stereotactic Body Radiation Therapy with Volumetric-Modulated Arcs and High-Intensity Photon Beams for the Treatment of Abdomino-Pelvic Lymph-Node Metastases.
    Franzese C; Cozzi L; Franceschini D; D'Agostino G; Comito T; De Rose F; Navarria P; Mancosu P; Tomatis S; Fogliata A; Scorsetti M
    Cancer Invest; 2016 Aug; 34(7):348-54. PubMed ID: 27414125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypofractionated stereotactic body radiotherapy in spinal metastasis - with or without epidural extension.
    Anand AK; Venkadamanickam G; Punnakal AU; Walia BS; Kumar A; Bansal AK; Singh HM
    Clin Oncol (R Coll Radiol); 2015 Jun; 27(6):345-52. PubMed ID: 25726363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salvage Stereotactic Body Radiotherapy for Patients With Prostate Cancer With Isolated Lymph Node Metastasis: A Single-Center Experience.
    Ponti E; Ingrosso G; Carosi A; Di Murro L; Lancia A; Pietrasanta F; Santoni R
    Clin Genitourin Cancer; 2015 Aug; 13(4):e279-e284. PubMed ID: 25604915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern of Progression after Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Nodal Recurrences.
    Ost P; Jereczek-Fossa BA; Van As N; Zilli T; Tree A; Henderson D; Orecchia R; Casamassima F; Surgo A; Miralbell R; De Meerleer G
    Clin Oncol (R Coll Radiol); 2016 Sep; 28(9):e115-20. PubMed ID: 27133946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robotic image-guided stereotactic radiotherapy, for isolated recurrent primary, lymph node or metastatic prostate cancer.
    Jereczek-Fossa BA; Beltramo G; Fariselli L; Fodor C; Santoro L; Vavassori A; Zerini D; Gherardi F; Ascione C; Bossi-Zanetti I; Mauro R; Bregantin A; Bianchi LC; De Cobelli O; Orecchia R
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):889-97. PubMed ID: 21277113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic/hypofractionated body radiation therapy as an effective treatment for lymph node metastases from colorectal cancer: an institutional retrospective analysis.
    Franzese C; Fogliata A; Comito T; Tozzi A; Iftode C; Clerici E; Franceschini D; Navarria P; Ascolese AM; Di Brina L; De Rose F; D'Agostino GR; Cozzi L; Scorsetti M
    Br J Radiol; 2017 Nov; 90(1079):20170422. PubMed ID: 28869396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Volumetric Intensity-Modulated Arc Stereotactic Radiosurgery Boost in Oligometastatic Patients with Spine Metastases: a Dose-escalation Study.
    Deodato F; Pezzulla D; Cilla S; Ferro M; Giannini R; Romano C; Boccardi M; Buwenge M; Valentini V; Morganti AG; Macchia G
    Clin Oncol (R Coll Radiol); 2023 Jan; 35(1):e30-e39. PubMed ID: 36207236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term local control achieved after hypofractionated stereotactic body radiotherapy for adrenal gland metastases: a retrospective analysis of 34 patients.
    Scorsetti M; Alongi F; Filippi AR; Pentimalli S; Navarria P; Clerici E; Castiglioni S; Tozzi A; Reggiori G; Mancosu P; Ricardi U
    Acta Oncol; 2012 May; 51(5):618-23. PubMed ID: 22263925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic body radiation therapy for abdominal and pelvic oligometastases: Dosimetric targets for safe and effective local control.
    Rwigema JM; King C; Wang PC; Kamrava M; Kupelian P; Steinberg ML; Lee P
    Pract Radiat Oncol; 2015; 5(3):e183-e191. PubMed ID: 25413386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic Body Radiotherapy (SBRT) for Spinal Metastases: Who Will Benefit the Most from SBRT?
    Park HJ; Kim HJ; Won JH; Lee SC; Chang AR
    Technol Cancer Res Treat; 2015 Apr; 14(2):159-67. PubMed ID: 24502552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Single-fraction and Multi-fraction Stereotactic Radiotherapy for Patients with 18F-fluorodeoxyglucose Positron Emission Tomography-staged Pulmonary Oligometastases.
    Siva S; Kirby K; Caine H; Pham D; Kron T; Te Marvelde L; Whalley D; Stevens MJ; Foroudi F; MacManus M; Ball D; Eade T
    Clin Oncol (R Coll Radiol); 2015 Jun; 27(6):353-61. PubMed ID: 25698068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linear accelerator-based stereotactic body radiation therapy in the treatment of oligometastatic disease.
    Yamashita H; Ogita M; Aoki S; Abe O; Nakagawa K
    Mol Clin Oncol; 2020 Aug; 13(2):109-114. PubMed ID: 32714532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the role of Stereotactic Body Radiation Therapy in a large cohort of patients with lymph node oligometastases: Does it affect systemic treatment's intensification?
    Franzese C; Badalamenti M; Comito T; Franceschini D; Clerici E; Navarria P; Loi M; D'agostino G; Baldaccini D; Chiola I; Reggiori G; Mancosu P; Tomatis S; Scorsetti M
    Radiother Oncol; 2020 Sep; 150():184-190. PubMed ID: 32593644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Locoregional control and survival after lymph node SBRT in oligometastatic disease.
    Loi M; Frelinghuysen M; Klass ND; Oomen-De Hoop E; Granton PV; Aerts J; Verhoef C; Nuyttens J
    Clin Exp Metastasis; 2018 Oct; 35(7):625-633. PubMed ID: 29995254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of stereotactic body radiation therapy (SBRT) in the treatment of oligometastatic disease in the elderly.
    Scorsetti M; Clerici E; Navarria P; D'Agostino G; Piergallini L; De Rose F; Ascolese A; Tozzi A; Iftode C; Villa E; Comito T; Franzese C; Mancosu P; Tomatis S; Cozzi L
    Br J Radiol; 2015 Sep; 88(1053):20150111. PubMed ID: 26183933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.